Access the full text.
Sign up today, get DeepDyve free for 14 days.
E. Nettis, P. Donne, E. Leo, G. Calogiuri, A. Ferrannini, A. Vacca (2013)
Rupatadine for the treatment of urticariaExpert Opinion on Pharmacotherapy, 14
Tomas Paulenda, P. Dráber (2016)
The role of ORMDL proteins, guardians of cellular sphingolipids, in asthmaAllergy, 71
E. Tang, P. Vanhoutte (2008)
Gene expression changes of prostanoid synthases in endothelial cells and prostanoid receptors in vascular smooth muscle cells caused by aging and hypertension.Physiological genomics, 32 3
Dave Singh, P. Cadden, M. Hunter, Lisa Collins, M. Perkins, R. Pettipher, Elizabeth Townsend, Shân Vinall, B. O’connor (2012)
Inhibition of the asthmatic allergen challenge response by the CRTH2 antagonist OC000459European Respiratory Journal, 41
W. Henderson, G. Chiang, Ying-tzang Tien, E. Chi (2006)
Reversal of allergen-induced airway remodeling by CysLT1 receptor blockade.American journal of respiratory and critical care medicine, 173 7
Z. Erbagci (2002)
The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: a single-blind, placebo-controlled, crossover clinical study.The Journal of allergy and clinical immunology, 110 3
F. Bossi, B. Frossi, O. Radillo, M. Cugno, A. Tedeschi, P. Riboldi, R. Asero, Francesco Tedesco, C. Pucillo (2011)
Mast cells are critically involved in serum‐mediated vascular leakage in chronic urticaria beyond high‐affinity IgE receptor stimulationAllergy, 66
T. Honda, Y. Tokura, Y. Miyachi, K. Kabashima (2010)
Prostanoid receptors as possible targets for anti-allergic drugs: recent advances in prostanoids on allergy and immunology.Current drug targets, 11 12
Marielle Köberlin, B. Snijder, L. Heinz, C. Baumann, Astrid Fauster, G. Vladimer, A. Gavin, G. Superti-Furga (2015)
A Conserved Circular Network of Coregulated Lipids Modulates Innate Immune ResponsesCell, 162
Gregory Kunkel, Michael Maceyka, S. Milstien, S. Spiegel (2013)
Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyondNature Reviews Drug Discovery, 12
C. Perry, Jane McGavin, C. Culy, T. Ibbotson (2003)
LatanoprostDrugs & Aging, 20
P. Jolly, M. Bektas, A. Olivera, C. González-Espinosa, R. Proia, J. Rivera, S. Milstien, S. Spiegel (2004)
Transactivation of Sphingosine-1–Phosphate Receptors by FcɛRI Triggering Is Required for Normal Mast Cell Degranulation and ChemotaxisThe Journal of Experimental Medicine, 199
B. Samuelsson, P. Borgeat, S. Hammarström, R. Murphy (1979)
Introduction of a nomenclature: leukotrienes.Prostaglandins, 17 6
G. Meer, D. Voelker, G. Feigenson (2008)
Membrane lipids: where they are and how they behaveNature Reviews Molecular Cell Biology, 9
T. Reiss, P. Chervinsky, R. Dockhorn, Sumiko Shingo, B. Seidenberg, Thomas Edwards (1998)
Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group.Archives of internal medicine, 158 11
G. Imokawa, Akihito Abe, K. Jin, Y. Higaki, M. Kawashima, A. Hidano (1991)
Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin?The Journal of investigative dermatology, 96 4
J. Nussbaum, S. Dyken, Jakob Moltke, Laurence Cheng, A. Mohapatra, Ari Molofsky, E. Thornton, M. Krummel, A. Chawla, Hong-Erh Liang, R. Locksley (2013)
Type 2 innate lymphoid cells control eosinophil homeostasisNature, 502
J. Murphy, S. Heptinstall, J. Mitchell (1988)
Randomised double-blind placebo-controlled trial of feverview in migraine preventionThe Lancet, 2
M. Kamiyama, A. Pozzi, L. Yang, L. Debusk, R. Breyer, P. Lin (2006)
EP2, a receptor for PGE2, regulates tumor angiogenesis through direct effects on endothelial cell motility and survivalOncogene, 25
Michael Maceyka, S. Spiegel (2014)
Sphingolipid metabolites in inflammatory diseaseNature, 510
Sinéad Miggin, B. Kinsella (2002)
Investigation of the Mechanisms of G Protein: Effector Coupling by the Human and Mouse Prostacyclin ReceptorsThe Journal of Biological Chemistry, 277
(2016)
Hematopoietic prostaglandin D synthase defines a proeosinophilic pathogenic effector human TH2 cell subpopulation with enhanced function
J. Jensen, S. Pfeiffer, M. Witt, M. Bräutigam, C. Neumann, M. Weichenthal, T. Schwarz, R. Fölster-Holst, E. Proksch (2009)
Different effects of pimecrolimus and betamethasone on the skin barrier in patients with atopic dermatitis.The Journal of allergy and clinical immunology, 123 5
Francine Ducharme, Hicks Gc (2000)
Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma.The Cochrane database of systematic reviews, 3
Jeroen Tibboel, I. Reiss, J. Jongste, M. Post (2014)
Sphingolipids in lung growth and repair.Chest, 145 1
T. Matsuoka, Masakazu Hirata, Hiroyuki Tanaka, Yoshimasa Takahashi, T. Murata, Kenji Kabashima, Y. Sugimoto, Takuya Kobayashi, F. Ushikubi, Yoshiya Aze, N. Eguchi, Yoshihiro Urade, N. Yoshida, Kazushi Kimura, Akira Mizoguchi, Yoshihito Honda, Hiroichi Nagai, S. Narumiya (2000)
Prostaglandin D2 as a mediator of allergic asthma.Science, 287 5460
Patricia Gangoiti, Luz Camacho, Lide Arana, A. Ouro, M. Granado, Leyre Brizuela, J. Casas, G. Fabriàs, J. Abad, Antonio Delgado, A. Gomez-Muñoz (2010)
Control of metabolism and signaling of simple bioactive sphingolipids: Implications in disease.Progress in lipid research, 49 4
P. Vadas, Boris Perelman, G. Liss (2008)
Platelet-activating factor, histamine, and tryptase levels in human anaphylaxis.The Journal of allergy and clinical immunology, 131 1
Alexander Andreyev, E. Fahy, Z. Guan, Samuel Kelly, Xiang Li, Jeffrey McDonald, S. Milne, D. Myers, Hyejung Park, Andrea Ryan, Bonne Thompson, E. Wang, Yihua Zhao, H. Brown, Alfred Merrill, C. Raetz, David Russell, S. Subramaniam, Edward Dennis (2010)
Subcellular organelle lipidomics in TLR-4-activated macrophages1[S]Journal of Lipid Research, 51
Megan Price, D. Kapitonov, J. Allegood, S. Milstien, C. Oskeritzian, S. Spiegel (2009)
Sphingosine‐1‐phosphate induces development of functionally mature chymase‐expressing human mast cells from hematopoietic progenitorsThe FASEB Journal, 23
Andrew Cowburn, S. Holgate, Anthony Sampson (1999)
IL-5 increases expression of 5-lipoxygenase-activating protein and translocates 5-lipoxygenase to the nucleus in human blood eosinophils.Journal of immunology, 163 1
M. Miligkos, R. Bannuru, H. Alkofide, S. Kher, C. Schmid, E. Balk (2015)
Leukotriene-receptor antagonists versus placebo in the treatment of asthma in adults and adolescents: a systematic review and meta-analysis.Annals of internal medicine, 163 10
A. Mccook (2004)
Sune K BergströmThe Lancet, 364
S. Wenzel, S. Szefler, D. Leung, Steven Sloan, M. Rex, R. Martin (1997)
Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids.American journal of respiratory and critical care medicine, 156 3 Pt 1
I. Moshkovits, D. Shik, M. Itan, D. Karo-Atar, B. Bernshtein, A. Hershko, M. Campagne, A. Munitz (2013)
CMRF35-like molecule 1 (CLM-1) regulates eosinophil homeostasis by suppressing cellular chemotaxisMucosal Immunology, 7
P. Vadas, M. Gold, Boris Perelman, Gary Liss, G. Lack, T. Blyth, F. Simons, K. Simons, D. Cass, J. Yeung (2008)
Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis.The New England journal of medicine, 358 1
A. Straumann, S. Hoesli, C. Bussmann, M. Stuck, M. Perkins, L. Collins, M. Payton, R. Pettipher, M. Hunter, Jan Steiner, H. Simon (2013)
Anti‐eosinophil activity and clinical efficacy of the CRTH2 antagonist OC000459 in eosinophilic esophagitisAllergy, 68
H. Johnson, H. Johnson, Robert Chinn, A. Chow, M. Bach, J. Nadel (1983)
Leukotriene-C4 enhances mucus production from submucosal glands in canine trachea in vivo.International journal of immunopharmacology, 5 5
I. Hall, A. Fowler, Abhya Gupta, K. Tetzlaff, M. Nivens, M. Sarno, H. Finnigan, E. Bateman, E. Sutherland (2015)
Efficacy of BI 671800, an oral CRTH2 antagonist, in poorly controlled asthma as sole controller and in the presence of inhaled corticosteroid treatment.Pulmonary pharmacology & therapeutics, 32
R. Lewis, N. Soter, P. Diamond, K. Austen, J. Oates, L. Roberts (1982)
Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE.Journal of immunology, 129 4
J. Säfholm, M. Manson, J. Bood, I. Delin, Ann-Charlotte Orre, Per Bergman, Mamdoh Al-Ameri, S. Dahlén, M. Adner (2015)
Prostaglandin E2 inhibits mast cell-dependent bronchoconstriction in human small airways through the E prostanoid subtype 2 receptor.The Journal of allergy and clinical immunology, 136 5
M. Pierzchalska, Z. Szabó, M. Sanak, J. Soja, A. Szczeklik (2003)
Deficient prostaglandin E2 production by bronchial fibroblasts of asthmatic patients, with special reference to aspirin-induced asthma.The Journal of allergy and clinical immunology, 111 5
M. Fajt, Stacy Gelhaus, B. Freeman, Crystal Uvalle, J. Trudeau, F. Holguin, S. Wenzel (2013)
Prostaglandin D₂ pathway upregulation: relation to asthma severity, control, and TH2 inflammation.The Journal of allergy and clinical immunology, 131 6
Jeffrey Cohen, F. Barkhof, G. Comi, H. Hartung, B. Khatri, X. Montalban, J. Pelletier, R. Capra, P. Gallo, G. Izquierdo, K. Tiel‐Wilck, A. Vera, James Jin, T. Stites, Stacy Wu, S. Aradhye, L. Kappos (2010)
Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis.The New England journal of medicine, 362 5
C. Christoffersen, Hideru Obinata, Sunil Kumaraswamy, S. Galvani, J. Ahnström, M. Sevvana, C. Egerer-Sieber, Y. Muller, T. Hla, L. Nielsen, B. Dahlbäck (2011)
Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein MProceedings of the National Academy of Sciences, 108
Drew Miller, Sarah Koch, B. Yentzer, A. Clark, Jenna O'Neill, J. Fountain, T. Weber, A. Fleischer (2011)
An over-the-counter moisturizer is as clinically effective as, and more cost-effective than, prescription barrier creams in the treatment of children with mild-to-moderate atopic dermatitis: a randomized, controlled trial.Journal of drugs in dermatology : JDD, 10 5
A. Sousa, A. Parikh, G. Scadding, C. Corrigan, Tak Lee (2002)
Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis.The New England journal of medicine, 347 19
M. Griffin, J. Weiss, A. Leitch, E. Mcfadden, E. Corey, K. Austen, J. Drazen (1983)
Effects of leukotriene D on the airways in asthma.The New England journal of medicine, 308 8
Kumi Izawa, Y. Yamanishi, Akie Maehara, Mariko Takahashi, Masamichi Isobe, S. Ito, Ayako Kaitani, T. Matsukawa, T. Matsuoka, F. Nakahara, T. Oki, H. Kiyonari, T. Abe, K. Okumura, T. Kitamura, J. Kitaura (2012)
The receptor LMIR3 negatively regulates mast cell activation and allergic responses by binding to extracellular ceramide.Immunity, 37 5
B. Wilson, S. Steinberg, Karin Liederman, J. Pfeiffer, Z. Surviladze, Jun Zhang, L. Samelson, Li-hong Yang, P. Kotula, J. Oliver (2004)
Markers for detergent-resistant lipid rafts occupy distinct and dynamic domains in native membranes.Molecular biology of the cell, 15 6
Y. Kurashima, J. Kunisawa, Morio Higuchi, M. Gohda, I. Ishikawa, Naoko Takayama, Miki Shimizu, H. Kiyono (2007)
Sphingosine 1-Phosphate-Mediated Trafficking of Pathogenic Th2 and Mast Cells for the Control of Food Allergy1The Journal of Immunology, 179
H. Rosenberg, K. Dyer, P. Foster (2012)
Eosinophils: changing perspectives in health and diseaseNature Reviews. Immunology, 13
M. Kraft, C. Cairns, M. Ellison, J. Pak, C. Irvin, S. Wenzel (2006)
Improvements in distal lung function correlate with asthma symptoms after treatment with oral montelukast.Chest, 130 6
J. Drazen, Jeanne O'Brien, David Sparrow, Scott Weiss, Milton Martins, Elliot Israel, Christopher Fanta (1992)
Recovery of leukotriene E4 from the urine of patients with airway obstruction.The American review of respiratory disease, 146 1
J. Mullol, J. Bousquet, C. Bachert, G. Canonica, A. Giménez-Arnau, M. Kowalski, F. Simons, M. Maurer, D. Ryan, G. Scadding (2015)
Update on rupatadine in the management of allergic disordersAllergy, 70
Fred Snyder (1995)
Platelet-activating factor: the biosynthetic and catabolic enzymes.The Biochemical journal, 305 ( Pt 3)
Marina Miller, P. Rosenthal, Andrew Beppu, James Mueller, H. Hoffman, A. Tam, T. Doherty, Matthew McGeough, C. Peña, M. Suzukawa, M. Niwa, D. Broide (2014)
ORMDL3 Transgenic Mice Have Increased Airway Remodeling and Airway Responsiveness Characteristic of AsthmaThe Journal of Immunology, 192
A. Nardo, Philip Wertz, Alberto Giannetti, S. Seidenari (1998)
Ceramide and cholesterol composition of the skin of patients with atopic dermatitis.Acta dermato-venereologica, 78 1
Joseph Kulinski, R. Muñoz-Cano, A. Olivera (2016)
Sphingosine-1-phosphate and other lipid mediators generated by mast cells as critical players in allergy and mast cell function.European journal of pharmacology, 778
B. Vargaftig, M. Singer (2003)
Leukotrienes mediate murine bronchopulmonary hyperreactivity, inflammation, and part of mucosal metaplasia and tissue injury induced by recombinant murine interleukin-13.American journal of respiratory cell and molecular biology, 28 4
M. Pienkowski, N. Adkinson, M. Plaut, P. Norman, L. Lichtenstein (1988)
Prostaglandin D2 and histamine during the immediate and the late-phase components of allergic cutaneous responses.The Journal of allergy and clinical immunology, 82 1
Jacques Benveniste (1974)
Platelet-activating factor, a new mediator of anaphylaxis and immune complex deposition from rabbit and human basophilsNature, 249
Petra Luschnig-Schratl, E. Sturm, V. Kónya, S. Philipose, G. Marsche, E. Fröhlich, C. Samberger, D. Lang‐Loidolt, S. Gattenlöhner, I. Lippe, B. Peskar, R. Schuligoi, A. Heinemann (2011)
EP4 receptor stimulation down-regulates human eosinophil functionCellular and Molecular Life Sciences, 68
R. Chaudhuri, V. Norris, K. Kelly, Chang-Qing Zhu, C. Ambery, J. Lafferty, E. Cameron, Neil Thomson (2014)
Effects of a FLAP inhibitor, GSK2190915, in asthmatics with high sputum neutrophils.Pulmonary pharmacology & therapeutics, 27 1
H. Rosen, R. Stevens, M. Hanson, E. Roberts, M. Oldstone (2013)
Sphingosine-1-phosphate and its receptors: structure, signaling, and influence.Annual review of biochemistry, 82
A. Kihara, S. Mitsutake, Y. Mizutani, Y. Igarashi (2007)
Metabolism and biological functions of two phosphorylated sphingolipids, sphingosine 1-phosphate and ceramide 1-phosphate.Progress in lipid research, 46 2
I. Petrache, V. Natarajan, Lijie Zhen, Terry Medler, Amy Richter, E. Berdyshev, R. Tuder (2006)
Ceramide causes pulmonary cell apoptosis and emphysema: a role for sphingolipid homeostasis in the maintenance of alveolar cells.Proceedings of the American Thoracic Society, 3 6
H. Gong, W. Linn, S. Terrell, K. Anderson, K. Clark (2001)
Anti-inflammatory and lung function effects of montelukast in asthmatic volunteers exposed to sulfur dioxide.Chest, 119 2
F. Cuss, C. Dixon, P. Barnes (1986)
EFFECTS OF INHALED PLATELET ACTIVATING FACTOR ON PULMONARY FUNCTION AND BRONCHIAL RESPONSIVENESS IN MANThe Lancet, 328
P. Creticos, S. Peters, N. Adkinson, R. Naclerio, E. Hayes, P. Norman, L. Lichtenstein (1984)
Peptide leukotriene release after antigen challenge in patients sensitive to ragweed.The New England journal of medicine, 310 25
M. Serra‐Pagès, A. Olivera, R. Torres, C. Picado, F. Mora, J. Rivera (2012)
E‐prostanoid 2 receptors dampen mast cell degranulation via cAMP/PKA‐mediated suppression of IgE‐dependent signalingJournal of Leukocyte Biology, 92
W. Phipatanakul, C. Greene, Sandra Downes, B. Cronin, T. Eller, L. Schneider, A. Irani (2003)
Montelukast improves asthma control in asthmatic children maintained on inhaled corticosteroids.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 91 1
M. Surma, C. Klose, K. Simons (2012)
Lipid-dependent protein sorting at the trans-Golgi network.Biochimica et biophysica acta, 1821 8
H. Olschewski (2009)
Inhaled iloprost for the treatment of pulmonary hypertensionEuropean Respiratory Review, 18
M. Liu, L. Dubé, J. Lancaster (1996)
Acute and chronic effects of a 5-lipoxygenase inhibitor in asthma: A 6-month randomized multicenter trial
D. Stafforini, T. McIntyre, G. Zimmerman, S. Prescott (2003)
Platelet-Activating Factor, a Pleiotrophic Mediator of Physiological and Pathological ProcessesCritical Reviews in Clinical Laboratory Sciences, 40
V. Kónya, Andreas Uellen, Nora Kampitsch, A. Theiler, S. Philipose, G. Parzmair, G. Marsche, B. Peskar, R. Schuligoi, W. Sattler, A. Heinemann (2013)
Endothelial E-type prostanoid 4 receptors promote barrier function and inhibit neutrophil trafficking.The Journal of allergy and clinical immunology, 131 2
A. Ford-hutchinson, M. Bray, M. Doig, M. Shipley, M. Smith (1980)
Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytesNature, 286
A. Futerman, Y. Hannun (2004)
The complex life of simple sphingolipidsEMBO reports, 5
Naoki Kajiwara, Tomomi Sasaki, P. Bradding, G. Cruse, H. Sagara, K. Ohmori, H. Saito, C. Ra, Y. Okayama (2010)
Activation of human mast cells through the platelet-activating factor receptor.The Journal of allergy and clinical immunology, 125 5
Yiqun Hui, Yan Cheng, I. Smalera, Wenying Jian, L. Goldhahn, G. FitzGerald, C. Funk (2004)
Directed Vascular Expression of Human Cysteinyl Leukotriene 2 Receptor Modulates Endothelial Permeability and Systemic Blood PressureCirculation, 110
Y. Kanaoka, J. Boyce (2014)
Cysteinyl Leukotrienes and Their Receptors; Emerging ConceptsAllergy, Asthma & Immunology Research, 6
M. Idzko, H. Hammad, M. Nimwegen, M. Kool, T. Müller, Thomas Soullié, M. Willart, D. Hijdra, H. Hoogsteden, B. Lambrecht (2006)
Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.The Journal of clinical investigation, 116 11
T. Mackle, S. Gendy, M. Walsh, R. Mcconn-Walsh, R. Costello, M. Walsh (2008)
Role of sphingosine 1-phosphate receptor expression in eosinophils of patients with allergic rhinitis, and effect of topical nasal steroid treatment on this receptor expressionThe Journal of Laryngology & Otology, 122
H. Sheng, J. Shao, J. Morrow, R. Beauchamp, R. Dubois (1998)
Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells.Cancer research, 58 2
Zhong-Jian Shen, S. Esnault, Anna Schinzel, C. Borner, J. Malter (2009)
The peptidyl-prolyl isomerase Pin1 facilitates cytokine-induced survival of eosinophils by suppressing Bax activationNature immunology, 10
S. Hamanaka, M. Hara, H. Nishio, F. Otsuka, A. Suzuki, Y. Uchida (2002)
Human epidermal glucosylceramides are major precursors of stratum corneum ceramides.The Journal of investigative dermatology, 119 2
D. Price, S. Musgrave, L. Shepstone, E. Hillyer, E. Sims, Richard Gilbert, E. Juniper, J. Ayres, L. Kemp, Annie Blyth, E. Wilson, S. Wolfe, Daryl Freeman, H. Mugford, J. Murdoch, I. Harvey (2011)
Leukotriene antagonists as first-line or add-on asthma-controller therapy.The New England journal of medicine, 364 18
E. Israel, Andrew Fischer, Mitchell Rosenberg, C. Lilly, J. Callery, J. Shapiro, J. Cohn, P. Rubin, J. Drazen (1993)
The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin.The American review of respiratory disease, 148 6 Pt 1
Y. Kihara, Shakti Gupta, M. Maurya, Aaron Armando, Ishita Shah, O. Quehenberger, C. Glass, E. Dennis, S. Subramaniam (2014)
Modeling of eicosanoid fluxes reveals functional coupling between cyclooxygenases and terminal synthases.Biophysical journal, 106 4
A. Ammit, A. Hastie, L. Edsall, R. Hoffman, Y. Amrani, V. Krymskaya, S. Kane, S. Peters, R. Penn, S. Spiegel, R. Panettieri (2001)
Sphingosine 1‐phosphate modulates human airway smooth muscle cell functions that promote inflammation and airway remodeling in asthmaThe FASEB Journal, 15
G. Dusting, S. Moncada, J. Vane (1977)
Prostacyclin (PGX) is the endogeneous metabolite responsible for relaxation of coronary arteries induced by arachidonic acidProstaglandins, 13
A. Trifilieff, J. Fozard (2012)
Sphingosine-1-Phosphate-Induced Airway Hyper-Reactivity in Rodents Is Mediated by the Sphingosine-1-Phosphate Type 3 ReceptorJournal of Pharmacology and Experimental Therapeutics, 342
S. Ha, X. Ge, N. Bahaie, B. Kang, Amrita Rao, Savita Rao, P. Sriramarao (2013)
ORMDL3 promotes eosinophil trafficking and activation via regulation of integrins and CD48Nature communications, 4
D. Wright, A. Ford-hutchinson, K. Chadee, K. Metters (2000)
The human prostanoid DP receptor stimulates mucin secretion in LS174T cellsBritish Journal of Pharmacology, 131
A. Olivera, Yoshiaki Kitamura, Laurel Wright, M. Allende, Weiping Chen, Tomomi Kaneko-Goto, Y. Yoshihara, R. Proia, J. Rivera (2013)
Sphingosine‐1‐phosphate can promote mast cell hyper‐reactivity through regulation of contactin‐4 expressionJournal of Leukocyte Biology, 94
A. Kasperska‐Zając, Z. Brzoza, Barbara Rogala (2008)
Platelet Activating Factor as a Mediator and Therapeutic Approach in Bronchial AsthmaInflammation, 31
T. Yokomizo, T. Izumi, Kyungho Chang, Y. Takuwa, Takao Shimizu (1997)
A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxisNature, 387
A. Fernandis, M. Wenk (2007)
Membrane lipids as signaling moleculesCurrent Opinion in Lipidology, 18
Chunli Feng, Elizabeth Beller, S. Bagga, J. Boyce (2006)
Human mast cells express multiple EP receptors for prostaglandin E2 that differentially modulate activation responses.Blood, 107 8
Yoshimasa Takahashi, Shota Tokuoka, T. Masuda, Yousuke Hirano, M. Nagao, Hiroyuki Tanaka, N. Inagaki, S. Narumiya, H. Nagai (2002)
Augmentation of allergic inflammation in prostanoid IP receptor deficient miceBritish Journal of Pharmacology, 137
D. Simanshu, R. Kamlekar, D. Wijesinghe, Xianqiong Zou, X. Zhai, S. Mishra, J. Molotkovsky, L. Malinina, E. Hinchcliffe, C. Chalfant, Rhoderick Brown, D. Patel (2013)
Nonvesicular trafficking by a ceramide-1-phosphate transfer protein regulates eicosanoidsNature, 500
E. Mellor, N. Frank, D. Soler, M. Hodge, J. Lora, K. Austen, J. Boyce (2003)
Expression of the type 2 receptor for cysteinyl leukotrienes (CysLT2R) by human mast cells: Functional distinction from CysLT1RProceedings of the National Academy of Sciences of the United States of America, 100
C. Kellaway, E. Trethewie (1940)
THE LIBERATION OF A SLOW‐REACTING SMOOTH MUSCLE‐STIMULATING SUBSTANCE IN ANAPHYLAXISExperimental Physiology, 30
F. Roviezzo, F. Galdo, G. Abbate, M. Bucci, B. D'Agostino, E. Antunes, G. Dominicis, L. Parente, F. Rossi, G. Cirino, R. Palma (2004)
Human eosinophil chemotaxis and selective in vivo recruitment by sphingosine 1-phosphate.Proceedings of the National Academy of Sciences of the United States of America, 101 30
I. Petrache, K. Kamocki, Christophe Poirier, Y. Pewzner‐Jung, Elad Laviad, K. Schweitzer, Mary Demark, M. Justice, W. Hubbard, A. Futerman (2013)
Ceramide Synthases Expression and Role of Ceramide Synthase-2 in the Lung: Insight from Human Lung Cells and Mouse ModelsPLoS ONE, 8
Fred Hsieh, Bing Lam, J. Penrose, K. Austen, Joshua Boyce (2001)
T Helper Cell Type 2 Cytokines Coordinately Regulate Immunoglobulin E–Dependent Cysteinyl Leukotriene Production by Human Cord Blood–Derived Mast CellsThe Journal of Experimental Medicine, 193
James Buckley, M. Birrell, Sarah Maher, A. Nials, Deborah Clarke, M. Belvisi (2011)
EP4 receptor as a new target for bronchodilator therapyThorax, 66
D. Price, D. Hernández, P. Magyar, J. Fiterman, K. Beeh, I. James, S. Konstantopoulos, R. Rojas, J. Noord, M. Pons, L. Gilles, J. Leff (2003)
Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthmaThorax, 58
A. Giménez-Arnau, I. Izquierdo, Marcus Maurer (2009)
The use of a responder analysis to identify clinically meaningful differences in chronic urticaria patients following placebo‐ controlled treatment with rupatadine 10 and 20 mgJournal of the European Academy of Dermatology and Venereology, 23
Bhupendrasinh Chauhan, F. Ducharme (2012)
Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children.The Cochrane database of systematic reviews, 5
F. Gaber, K. Daham, Ai Higashi, N. Higashi, Agneta Gulich, I. Delin, A. James, M. Skedinger, P. Gyllfors, M. Nord, S. Dahlén, M. Kumlin, B. Dahlén (2008)
Increased levels of cysteinyl-leukotrienes in saliva, induced sputum, urine and blood from patients with aspirin-intolerant asthmaThorax, 63
O. Choi, Jae-Heup Kim, J. Kinet (1996)
Calcium mobilization via sphingosine kinase in signalling by the FcɛRI antigen receptorNature, 380
D. Olson, Christina Ammann (2007)
Role of the prostaglandins in labour and prostaglandin receptor inhibitors in the prevention of preterm labour.Frontiers in bioscience : a journal and virtual library, 12
C. Vancheri, C. Mastruzzo, M. Sortino, N. Crimi (2004)
The lung as a privileged site for the beneficial actions of PGE2.Trends in immunology, 25 1
G. Zimmerman, T. McIntyre, S. Prescott, D. Stafforini (2002)
The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosisCritical Care Medicine, 30
K. Kabashima, T. Murata, Hiroyuki Tanaka, T. Matsuoka, Daiji Sakata, N. Yoshida, K. Katagiri, T. Kinashi, Toshiyuki Tanaka, M. Miyasaka, H. Nagai, F. Ushikubi, S. Narumiya (2003)
Thromboxane A2 modulates interaction of dendritic cells and T cells and regulates acquired immunityNature Immunology, 4
R. Maiti, Jyothirmai Jaida, B. Raghavendra, P. Goud, I. Ahmed, Anuradha Palani (2011)
Rupatadine and levocetirizine in chronic idiopathic urticaria: a comparative study of efficacy and safety.Journal of drugs in dermatology : JDD, 10 12
T. Laidlaw, J. Boyce (2013)
Pathogenesis of aspirin-exacerbated respiratory disease and reactions.Immunology and allergy clinics of North America, 33 2
G. D’Angelo, Serena Capasso, Lucia Sticco, D. Russo (2013)
Glycosphingolipids: synthesis and functionsThe FEBS Journal, 280
A. Langlands, W. Martin (1975)
Letter: Jaundice associated with norethisterone-acetate treatment of breast cancer.Lancet, 1 7906
Weisong Zhou, S. Toki, Jian Zhang, Kasia Goleniewksa, D. Newcomb, Jacqueline Cephus, D. Dulek, Melissa Bloodworth, M. Stier, Vasiliy Polosuhkin, Rama Gangula, Simon Mallal, D. Broide, R. Peebles (2015)
Prostaglandin I2 Signaling and Inhibition of Group 2 Innate Lymphoid Cell Responses.American journal of respiratory and critical care medicine, 193 1
J. Mjösberg, S. Trifari, N. Crellin, C. Peters, C. Drunen, B. Piet, W. Fokkens, T. Cupedo, H. Spits (2011)
Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161Nature Immunology, 12
C. Peacock, N. Misso, D. Watkins, P. Thompson (1999)
PGE 2 and dibutyryl cyclic adenosine monophosphate prolong eosinophil survival in vitro.The Journal of allergy and clinical immunology, 104 1
P. Srinivasan, B. Bahnson (2010)
Molecular Model of Plasma PAF Acetylhydrolase-Lipoprotein Association: Insights from the StructurePharmaceuticals, 3
Deanna Siow, B. Wattenberg (2012)
Mammalian ORMDL Proteins Mediate the Feedback Response in Ceramide Biosynthesis*The Journal of Biological Chemistry, 287
Shizhong Zhang, Xiaoyin Wu, Shaoyong Yu (2014)
Prostaglandin D2 receptor D-type prostanoid receptor 2 mediates eosinophil trafficking into the esophagus.Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus, 27 6
Masahiko Kato, Takafumi Yamaguchi, A. Tachibana, Masato Suzuki, T. Izumi, K. Maruyama, Y. Hayashi, H. Kimura (2004)
An atypical protein kinase C, PKC ζ, regulates human eosinophil effector functionsImmunology, 116
Takumi Tsuji, S. Okuno, Ayano Kuroda, Junya Hamazaki, Takuma Chikami, Sakura Sakurai, Yuya Yoshida, Rie Banno, T. Fujita, T. Kohno (2016)
Therapeutic approach to mite-induced intractable dermatitis using novel immunomodulator FTY720 ointment (fingolimod) in NC/Nga mice.Allergology international : official journal of the Japanese Society of Allergology, 65 2
M. Moffatt, I. Gut, F. Demenais, D. Strachan, E. Bouzigon, S. Heath, E. Mutius, M. Farrall, M. Lathrop, W. Cookson (2010)
A large-scale, consortium-based genomewide association study of asthma.The New England journal of medicine, 363 13
B. Weksler, A. Marcus, E. Jaffe (1977)
Synthesis of prostaglandin I2 (prostacyclin) by cultured human and bovine endothelial cells.Proceedings of the National Academy of Sciences of the United States of America, 74 9
N. Sawyer, E. Cauchon, A. Châteauneuf, Rani Cruz, D. Nicholson, K. Metters, G. O'neill, F. Gervais (2002)
Molecular pharmacology of the human prostaglandin D2 receptor, CRTH2British Journal of Pharmacology, 137
H. Shirasaki, E. Kanaizumi, N. Seki, T. Himi (2015)
Leukotriene E4 induces MUC5AC release from human airway epithelial NCI-H292 cells.Allergology international : official journal of the Japanese Society of Allergology, 64 2
E. Gelfand, A. Dakhama (2006)
CD8+ T lymphocytes and leukotriene B4: novel interactions in the persistence and progression of asthma.The Journal of allergy and clinical immunology, 117 3
F. Gervais, Rani Cruz, A. Châteauneuf, Stephen Gale, N. Sawyer, F. Nantel, K. Metters, G. O'neill (2001)
Selective modulation of chemokinesis, degranulation, and apoptosis in eosinophils through the PGD2 receptors CRTH2 and DP.The Journal of allergy and clinical immunology, 108 6
Karina Espinosa, Y. Bossé, J. Stankova, M. Rola-Pleszczynski (2003)
CysLT1 receptor upregulation by TGF-beta and IL-13, but not IL-4, is associated with bronchial smooth muscle cell proliferation in response to LTD4The Journal of Allergy and Clinical Immunology, 111
K. Harikumar, J. Yester, M. Surace, Clement Oyeniran, Megan Price, Wei‐Ching Huang, N. Hait, J. Allegood, A. Yamada, X. Kong, Helen Lazear, Reetika Bhardwaj, K. Takabe, M. Diamond, C. Luo, S. Milstien, S. Spiegel, T. Kordula (2014)
K63-linked polyubiquitination of transcription factor IRF1 is essential for IL-1-induced production of chemokines CXCL10 and CCL5Nature Immunology, 15
Kinya Nagata, Kazuya Tanaka, K. Ogawa, K. Kemmotsu, Toshio Imai, Osamu Yoshie, Hiroyuki Abe, K. Tada, M. Nakamura, K. Sugamura, S. Takano (1999)
Selective expression of a novel surface molecule by human Th2 cells in vivo.Journal of immunology, 162 3
J. Ruiz, M. Monreal, H. Sala, J. Roncalés, J. Fiz, E. Monso, J. Morera (1992)
Effects of inhaled platelet activating factor on bronchial responsiveness in patients with symptomatic and asymptomatic pulmonary embolism.Chest, 102 3
A. Hata, R. Breyer (2004)
Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation.Pharmacology & therapeutics, 103 2
Krishnan Venkataraman, Yong-Moon Lee, J. Michaud, S. Thangada, Youxi Ai, H. Bonkovsky, N. Parikh, Cheryl Habrukowich, T. Hla (2008)
Vascular Endothelium As a Contributor of Plasma Sphingosine 1-PhosphateCirculation Research, 102
S. Moncada, E. Higgs, J. Vane (1977)
HUMAN ARTERIAL AND VENOUS TISSUES GENERATE PROSTACYCLIN (PROSTAGLANDIN X), A POTENT INHIBITOR OF PLATELET AGGREGATIONThe Lancet, 309
Y. Kanaoka, A. Maekawa, K. Austen (2013)
Identification of GPR99 Protein as a Potential Third Cysteinyl Leukotriene Receptor with a Preference for Leukotriene E4 Ligand*The Journal of Biological Chemistry, 288
S. Hammad, J. Pierce, F. Soodavar, Kent Smith, Mohammed Gadban, B. Rembiesa, R. Klein, Y. Hannun, J. Bielawski, A. Bielawska (2010)
Blood sphingolipidomics in healthy humans: impact of sample collection methodologyJournal of Lipid Research, 51
Sandra Dillahunt, J. Sargent, R. Suzuki, R. Proia, A. Gilfillan, J. Rivera, A. Olivera (2013)
Usage of Sphingosine Kinase Isoforms in Mast Cells Is Species and/or Cell Type DeterminedThe Journal of Immunology, 190
David Breslow, Sean Collins, B. Bodenmiller, R. Aebersold, K. Simons, A. Shevchenko, Christer Ejsing, J. Weissman (2010)
Orm family proteins mediate sphingolipid homeostasisNature, 463
M. Peters-Golden, M. Gleason, A. Togias (2006)
Cysteinyl leukotrienes: multi-functional mediators in allergic rhinitisClinical and Experimental Allergy, 36
K. Takayama, G. Garcı́a-Cardeña, G. Sukhova, J. Comander, M. Gimbrone, P. Libby (2002)
Prostaglandin E2 Suppresses Chemokine Production in Human Macrophages through the EP4 Receptor*The Journal of Biological Chemistry, 277
A. Dixon, A. Dixon, L. Liang, M. Moffatt, Wei Chen, S. Heath, K. Wong, Jenny Taylor, E. Burnett, I. Gut, M. Farrall, G. Lathrop, G. Abecasis, W. Cookson (2007)
A genome-wide association study of global gene expressionNature Genetics, 39
R. Naclerio, H. Meier, A. Kagey-sobotka, N. Adkinson, D. Meyers, P. Norman, L. Lichtenstein (2015)
Mediator release after nasal airway challenge with allergen.The American review of respiratory disease, 134 5
Yiqing Cai, L. Bjermer, T. Halstensen (2003)
Bronchial mast cells are the dominating LTC4S-expressing cells in aspirin-tolerant asthma.American journal of respiratory cell and molecular biology, 29 6
J. Kemp, R. Dockhorn, G. Shapiro, Ha Nguyen, T. Reiss, B. Seidenberg, B. Knorr (1998)
Montelukast once daily inhibits exercise-induced bronchoconstriction in 6- to 14-year-old children with asthma.The Journal of pediatrics, 133 3
H. Hammad, Hendrik Heer, Thomas Soullié, H. Hoogsteden, F. Trottein, B. Lambrecht (2003)
Prostaglandin D2 Inhibits Airway Dendritic Cell Migration and Function in Steady State Conditions by Selective Activation of the D Prostanoid Receptor 1 1The Journal of Immunology, 171
H. Hirai, Kazuya Tanaka, O. Yoshie, K. Ogawa, K. Kenmotsu, Y. Takamori, M. Ichimasa, K. Sugamura, Masataka Nakamura, S. Takano, K. Nagata (2001)
Prostaglandin D2 Selectively Induces Chemotaxis in T Helper Type 2 Cells, Eosinophils, and Basophils via Seven-Transmembrane Receptor Crth2The Journal of Experimental Medicine, 193
G. Philip, C. Hustad, M. Malice, G. Noonan, A. Ezekowitz, T. Reiss, B. Knorr (2009)
Analysis of behavior-related adverse experiences in clinical trials of montelukast.The Journal of allergy and clinical immunology, 124 4
K. Shin, J. Hwang, Bo-in Kwon, F. Kheradmand, D. Corry, Seung-Hyo Lee (2015)
Leukotriene enhanced allergic lung inflammation through induction of chemokine productionClinical and Experimental Medicine, 15
H. Vesper, E. Schmelz, M. Nikolova-Karakashian, D. Dillehay, D. Lynch, A. Merrill (1999)
Sphingolipids in food and the emerging importance of sphingolipids to nutrition.The Journal of nutrition, 129 7
I. Dey, M. Lejeune, K. Chadee (2006)
Prostaglandin E2 receptor distribution and function in the gastrointestinal tractBritish Journal of Pharmacology, 149
E. Sturm, G. Parzmair, B. Radnai, R. Frei, G. Sturm, A. Hammer, R. Schuligoi, I. Lippe, A. Heinemann (2015)
Phosphoinositide‐dependent protein kinase 1 (PDK1) mediates potent inhibitory effects on eosinophilsEuropean Journal of Immunology, 45
Kazuya Tanaka, H. Hirai, S. Takano, Masataka Nakamura, K. Nagata (2004)
Effects of prostaglandin D2 on helper T cell functions.Biochemical and biophysical research communications, 316 4
J. Jungersted, T. Agner (2013)
Eczema and ceramides: an updateContact Dermatitis, 69
W. Busse, S. Wenzel, E. Meltzer, E. Kerwin, M. Liu, N. Zhang, Y. Chon, A. Budelsky, Joseph Lin, Shao-Lee Lin (2013)
Safety and efficacy of the prostaglandin D2 receptor antagonist AMG 853 in asthmatic patients.The Journal of allergy and clinical immunology, 131 2
B. Lam, K. Austen (2002)
Leukotriene C4 synthase: a pivotal enzyme in cellular biosynthesis of the cysteinyl leukotrienes.Prostaglandins & other lipid mediators, 68-69
K. Dyer, C. Percopo, Zhihui Xie, Zhao Yang, J. Kim, F. Davoine, Paige Lacy, K. Druey, R. Moqbel, H. Rosenberg (2010)
Mouse and Human Eosinophils Degranulate in Response to Platelet-Activating Factor (PAF) and LysoPAF via a PAF-Receptor–Independent Mechanism: Evidence for a Novel ReceptorThe Journal of Immunology, 184
T. Nishiuma, Y. Nishimura, T. Okada, E. Kuramoto, Y. Kotani, S. Jahangeer, Shun-ichi Nakamura (2008)
Inhalation of sphingosine kinase inhibitor attenuates airway inflammation in asthmatic mouse model.American journal of physiology. Lung cellular and molecular physiology, 294 6
T. Kobayashi, K. Mitsuo, I. Goto (1988)
Free sphingoid bases in normal murine tissues.European journal of biochemistry, 172 3
D. Verlaan, Soizik Berlivet, G. Hunninghake, Anne-Marie Madore, M. Larivière, Sanny Moussette, E. Grundberg, T. Kwan, Manon Ouimet, B. Ge, Rose Hoberman, M. Świątek, Joana Dias, Kevin Lam, Vonda Koka, E. Harmsen, M. Soto-Quiros, L. Avila, J. Celedón, S. Weiss, K. Dewar, D. Sinnett, C. Laprise, B. Raby, T. Pastinen, A. Naumova (2009)
Allele-specific chromatin remodeling in the ZPBP2/GSDMB/ORMDL3 locus associated with the risk of asthma and autoimmune disease.American journal of human genetics, 85 3
M. Moffatt, M. Kabesch, L. Liang, A. Dixon, D. Strachan, S. Heath, M. Depner, A. Berg, A. Bufe, E. Rietschel, A. Heinzmann, Burkard Simma, T. Frischer, S. Willis-Owen, K. Wong, T. Illig, C. Vogelberg, S. Weiland, E. Mutius, G. Abecasis, M. Farrall, I. Gut, G. Lathrop, W. Cookson (2007)
Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthmaNature, 448
K. Leidl, G. Liebisch, D. Richter, G. Schmitz (2008)
Mass spectrometric analysis of lipid species of human circulating blood cells.Biochimica et biophysica acta, 1781 10
S. Diesner, A. Olivera, Sandra Dillahunt, Cornelia Schultz, Thomas Watzlawek, E. Förster-Waldl, A. Pollak, E. Jensen‐Jarolim, E. Untersmayr, J. Rivera (2012)
Sphingosine-kinase 1 and 2 contribute to oral sensitization and effector phase in a mouse model of food allergy.Immunology letters, 141 2
K. Pałgan, Z. Bartuzi (2015)
Platelet activating factor in allergiesInternational Journal of Immunopathology and Pharmacology, 28
R. Bae, A. Arteaga, J. Raj, B. Ibe (2011)
Albuterol Isomers Modulate Platelet-Activating Factor Synthesis and Receptor Signaling in Human Bronchial Smooth Muscle CellsInternational Archives of Allergy and Immunology, 158
R. Edukulla, Kira Rehn, Bo Liu, J. Mcalees, G. Hershey, Yui-Hsi Wang, I. Lewkowich, A. Lindsley (2016)
Intratracheal myriocin enhances allergen‐induced Th2 inflammation and airway hyper‐responsivenessImmunity, Inflammation and Disease, 4
J. Drazen, E. Israel, P. O'Byrne (1999)
Correction: Treatment of Asthma with Drugs Modifying the Leukotriene Pathway.The New England journal of medicine, 341 21
T. Zuberbier, C. Pfrommer, J. Beinhölzl, K. Hartmann, J. Ricklinkat, B. Czarnetzki (1995)
Gangliosides enhance IgE receptor-dependent histamine and LTC4 release from human mast cells.Biochimica et biophysica acta, 1269 1
Kumi Izawa, Masamichi Isobe, T. Matsukawa, S. Ito, Akie Maehara, Mariko Takahashi, Y. Yamanishi, Ayako Kaitani, T. Oki, K. Okumura, T. Kitamura, J. Kitaura (2014)
Sphingomyelin and ceramide are physiological ligands for human LMIR3/CD300f, inhibiting FcεRI-mediated mast cell activation.The Journal of allergy and clinical immunology, 133 1
L. Petersen, M. Church, P. Skov (1997)
Platelet-activating factor induces histamine release from human skin mast cells in vivo, which is reduced by local nerve blockade.The Journal of allergy and clinical immunology, 99 5
Tarek Taha, K. Argraves, L. Obeid (2004)
Sphingosine-1-phosphate receptors: receptor specificity versus functional redundancy.Biochimica et biophysica acta, 1682 1-3
D. Bukstein, A. Luskin, A. Bernstein (2003)
"Real-world" effectiveness of daily controller medicine in children with mild persistent asthma.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 90 5
G. Dakhale, Abhijit Shinde, M. Mahatme, Sachin Hiware, Dharmendra Mishra, J. Mukhi, Anoop Salve (2014)
Clinical effectiveness and safety of cetirizine versus rupatadine in chronic spontaneous urticaria: a randomized, double‐blind, 6‐week trialInternational Journal of Dermatology, 53
G. Taylor, P. Black, N. Turner, I. Taylor, N. Maltby, R. Fuller, C. Dollery (1989)
URINARY LEUKOTRIENE E4 AFTER ANTIGEN CHALLENGE AND IN ACUTE ASTHMA AND ALLERGIC RHINITISThe Lancet, 333
S. Galli, M. Tsai (2012)
IgE and mast cells in allergic diseaseNature Medicine, 18
G. Philip, C. Hustad, G. Noonan, M. Malice, A. Ezekowitz, T. Reiss, B. Knorr (2009)
Reports of suicidality in clinical trials of montelukast.The Journal of allergy and clinical immunology, 124 4
A. Olivera, Sandra Dillahunt, J. Rivera (2013)
Interrogation of sphingosine-1-phosphate receptor 2 function in vivo reveals a prominent role in the recovery from IgE and IgG-mediated anaphylaxis with minimal effect on its onset.Immunology letters, 150 1-2
J. Vane, R. Botting (1995)
Pharmacodynamic profile of prostacyclin.The American journal of cardiology, 75 3
I. Mohri, K. Kadoyama, T. Kanekiyo, Yo Sato, K. Kagitani-Shimono, Yuko Saito, Kinuko Suzuki, T. Kudo, M. Takeda, Y. Urade, S. Murayama, M. Taniike (2007)
Hematopoietic Prostaglandin D Synthase and DP1 Receptor Are Selectively Upregulated in Microglia and Astrocytes Within Senile Plaques From Human Patients and in a Mouse Model of Alzheimer DiseaseJournal of Neuropathology and Experimental Neurology, 66
R. Pappu, S. Schwab, I. Cornelissen, J. Pereira, J. Regard, Ying Xu, E. Camerer, Yaowu Zheng, Yong Huang, J. Cyster, S. Coughlin (2007)
Promotion of Lymphocyte Egress into Blood and Lymph by Distinct Sources of Sphingosine-1-PhosphateScience, 316
A. KleinJan, M. Nimwegen, K. Leman, H. Hoogsteden, B. Lambrecht (2013)
Topical treatment targeting sphingosine‐1‐phosphate and sphingosine lyase abrogates experimental allergic rhinitis in a murine modelAllergy, 68
A. Olivera, N. Urtz, K. Mizugishi, Y. Yamashita, A. Gilfillan, Y. Furumoto, Haihua Gu, R. Proia, T. Baumruker, J. Rivera (2006)
IgE-dependent Activation of Sphingosine Kinases 1 and 2 and Secretion of Sphingosine 1-Phosphate Requires Fyn Kinase and Contributes to Mast Cell Responses*Journal of Biological Chemistry, 281
Kacee Sims, C. Haynes, Samuel Kelly, J. Allegood, E. Wang, A. Momin, Martina Leipelt, Donna Reicher, C. Glass, M. Cameron, Sullards, A. Merrill (2010)
Kdo2-Lipid A, a TLR4-specific Agonist, Induces de Novo Sphingolipid Biosynthesis in RAW264.7 Macrophages, Which Is Essential for Induction of Autophagy*The Journal of Biological Chemistry, 285
C. Funk (2001)
Prostaglandins and leukotrienes: advances in eicosanoid biology.Science, 294 5548
David Gendron, A. Lemay, C. Tremblay, L. Lai, A. Langlois, Émilie Bernatchez, N. Flamand, Marie-Renée Blanchet, A. Don, Y. Bossé, É. Bissonnette, D. Marsolais (2015)
Treatment with a sphingosine analog after the inception of house dust mite-induced airway inflammation alleviates key features of experimental asthmaRespiratory Research, 16
Megan Price, C. Oskeritzian, Yves Falanga, K. Harikumar, J. Allegood, Sergio Alvarez, D. Conrad, J. Ryan, S. Milstien, S. Spiegel (2013)
A specific sphingosine kinase 1 inhibitor attenuates airway hyperresponsiveness and inflammation in a mast cell-dependent murine model of allergic asthma.The Journal of allergy and clinical immunology, 131 2
S. Aggarwal, Y. Moodley, P. Thompson, N. Misso (2009)
Prostaglandin E2 and cysteinyl leukotriene concentrations in sputum: association with asthma severity and eosinophilic inflammationClinical & Experimental Allergy, 40
Y. Boie, N. Sawyer, D. Slipetz, K. Metters, M. Abramovitz (1995)
Molecular Cloning and Characterization of the Human Prostanoid DP Receptor (*)The Journal of Biological Chemistry, 270
B. Pettus, A. Bielawska, Preeti Subramanian, D. Wijesinghe, Michael Maceyka, C. Leslie, John Evans, J. Freiberg, P. Roddy, Y. Hannun, C. Chalfant (2004)
Ceramide 1-Phosphate Is a Direct Activator of Cytosolic Phospholipase A2*Journal of Biological Chemistry, 279
Bioactive lipids are critical regulators of inflammation. Over the last 75 years, these diverse compounds have emerged as clinically-relevant mediators of allergic disease pathophysiology. Animal and human studies have demonstrated the importance of lipid mediators in the development of asthma, allergic rhinitis, urticaria, anaphylaxis, atopic dermatitis, and food allergy. Lipids are critical participants in cell signaling events which influence key physiologic (bronchoconstriction) and immune phenomena (degranulation, chemotaxis, sensitization). Lipid-mediated cellular mechanisms including: (1) formation of structural support platforms (lipid rafts) for receptor signaling complexes, (2) activation of a diverse family of G-protein coupled receptors, and (3) mediating intracellular signaling cascades by acting as second messengers. Here, we review four classes of bioactive lipids (platelet activating factor, the leukotrienes, the prostanoids, and the sphingolipids) with special emphasis on lipid synthesis pathways and signaling, atopic disease pathology, and the ongoing development of atopy treatments targeting lipid mediator pathways.
Current Allergy and Asthma Reports – Springer Journals
Published: Jun 22, 2016
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.